1 / 10

Challenges in the Management of Osteoporosis and Vitamin D Deficiency in the HIV-Infected Patient

Challenges in the Management of Osteoporosis and Vitamin D Deficiency in the HIV-Infected Patient. Todd T. Brown, MD, PhD Associate Professor of Medicine and Epidemiology The Johns Hopkins University School of Medicine Atlanta, GA. From TT Brown, MD, at Atlanta, GA: April 10, 2013, IAS-USA.

tim
Download Presentation

Challenges in the Management of Osteoporosis and Vitamin D Deficiency in the HIV-Infected Patient

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Challenges in the Management of Osteoporosis and Vitamin D Deficiency in the HIV-Infected Patient Todd T. Brown, MD, PhDAssociate Professor of Medicineand EpidemiologyThe Johns Hopkins UniversitySchool of MedicineAtlanta, GA From TT Brown, MD, at Atlanta, GA: April 10, 2013, IAS-USA.

  2. Pathophysiology and Risk Factors HIV Disease Factors Inflammation and Viral Proteins ↑ bone resorption ↓ bone formation Medication Factors Tenofovir Certain PIs (ATV/r) ART initiation (↓ 2-6% over 96 weeks)

  3. Pathophysiology and Risk Factors Patient-Related Factors Low Body Weight Smoking Alcohol Use Opiate Use Hepatitis C Co-infection Physical Inactivity Hypogonadism Low Vitamin D

  4. “we recommend a DXA scan for all HIV-infected post-menopausal women and men >50 years” CID, October 2010

  5. Definitions Functional Definition (DXA)- WHO Definition Osteoporosis: T-score < -2.5 Osteopenia: T-score= -1.0 to -2.5 Normal: T-score > -1.0 ↑ Risk of fracture by 1.5-3.0 x for each SD decrease Caveats: Z-score (<-2.0) used in men < 50 years and premenopausal women BMD explains only about 50% of fracture risk

  6. 2008 US NOF Guidelines: Who to Treat* Those with hip or vertebral fractures Those with BMD T-scores ≤ -2.5 at the femoral neck, total hip, or spine by DXA Those with T-score b/t -1 and -2.5 (osteopenia) at above sites AND 10-year hip fracture probability ≥ 3% or 10-year all major osteoporosis-related fracture ≥ 20% based on FRAX model *applies to post-menopausal women and men ≥ 50 years

  7. Secondary Causes of Low BMD • Vitamin D deficiency 25 OH Vit D • Hyperparathyroidism PTH, Ca++ • Subclinical Hyperthyroidism TSH • Hypogonadism Males: Free Testosterone • Phosphate wasting Fractional Excretion of Phosphate • Idiopathic Hypercalciuria 24 hr Urinary Calcium • Celiac Sprue Tissue Transglutaminase • Multiple Myeloma Serum Protein Electrophoresis • Mastocytosis  Serum Tryptase • Cushing’s Syndrome  24 hr Urinary Free Cortisol

  8. Dealing with Vitamin D: My Strategy • If BMD is low or history of falls, check 25OHD: • >30 ng/mL: 1000 IU/d • 20-30 ng/mL: 2000 IU/d • 15-20 ng/mL: Ergocalciferol 50K units weekly x 8 weeks, then D3 2000 IU/d • <15 ng/mL: Ergocalciferol 50K units once or twice a week x 8-12 weeks, then D3 2000 IU/d, recheck 25OHD after ergo course • More aggressive replacement if PTH is high or s/s of osteomalacia

  9. Management Options • General recommendations • Calcium/vitamin D supplementation • Smoking cessation, alcohol reduction • Weight-bearing exercise • Assess fall risk (Are you worried about falling?) • Strength/balance training • Rx options • Bisphosphonates • Selective estrogen receptor modulator • Estrogen • PTH analogue

  10. Conclusions DXA screening recommended in HIV-infected patients in men > 50 yrs and post-menopausal women Treatment guidelines should follow those established for the general population Remember secondary causes (vit D def and phosphate wasting) Use absolute risk of fracture to help guide decision making

More Related